J Clin Microbiol. 1994 November; 32(11): 2791-2800
Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.
F Chen and
M T Cushion
Department of Internal Medicine, University of Cincinnati College of Medicine, Ohio 45267-0560.
ABSTRACT
A bioluminescent assay which employs the luciferin-luciferase ATP-dependent reaction was used to evaluate the viability of populations of Pneumocystis carinii derived from infected rat lungs. Contamination with host cells was reduced by a purification method which involved a combination of low- and high-speed centrifugations resulting in a 1,000-fold reduction of the rat cells while enriching for the trophic form of P. carinii. A linear correlation for the number of P. carinii nuclei versus the amount of ATP was observed. The ATP content of the organism populations could be maintained at inoculum levels for one week, although the number of organisms did not increase. Addition of respiratory chain inhibitors dramatically decreased the ATP content of the P. carinii after 24 h of incubation, with the exception of the antibiotic oligomycin B. Low concentrations of trimethoprim-sulfamethoxazole and pentamidine isethionate reduced the organism ATP content by over 50% after 24 h of exposure, while no effect was observed with 100-fold greater concentrations of ampicillin. The bioluminescent assay was found to be a more sensitive indicator of viability than a dual fluorescent staining technique. This assay does not require replication of P. carinii and should be a useful method for in vitro drug screening and viability assessment of P. carinii populations.
J Clin Microbiol. 1994 November; 32(11): 2791-2800
This article has been cited by other articles:
-
Tachado, S. D., Zhang, J., Zhu, J., Patel, N., Cushion, M., Koziel, H.
(2007). Pneumocystis-mediated IL-8 release by macrophages requires coexpression of mannose receptors and TLR2. J. Leukoc. Biol.
81: 205-211
[Abstract]
[Full Text]
-
Cushion, M. T., Walzer, P. D., Ashbaugh, A., Rebholz, S., Brubaker, R., Vanden Eynde, J. J., Mayence, A., Huang, T. L.
(2006). In Vitro Selection and In Vivo Efficacy of Piperazine- and Alkanediamide-Linked Bisbenzamidines against Pneumocystis Pneumonia in Mice.. Antimicrob. Agents Chemother.
50: 2337-2343
[Abstract]
[Full Text]
-
Icenhour, C. R., Kottom, T. J., Limper, A. H.
(2006). Pneumocystis Melanins Confer Enhanced Organism Viability. Eukaryot Cell
5: 916-923
[Abstract]
[Full Text]
-
Vuk-Pavlovic, Z., Mo, E. K., Icenhour, C. R., Standing, J. E., Fisher, J. H., Limper, A. H.
(2006). Surfactant protein D enhances Pneumocystis infection in immune-suppressed mice. Am. J. Physiol. Lung Cell. Mol. Physiol.
290: L442-L449
[Abstract]
[Full Text]
-
Zhang, J., Tachado, S. D., Patel, N., Zhu, J., Imrich, A., Manfruelli, P., Cushion, M., Kinane, T. B., Koziel, H.
(2005). Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro. J. Leukoc. Biol.
78: 665-674
[Abstract]
[Full Text]
-
Zhang, J., Zhu, J., Bu, X., Cushion, M., Kinane, T. B., Avraham, H., Koziel, H.
(2005). Cdc42 and RhoB Activation Are Required for Mannose Receptor-mediated Phagocytosis by Human Alveolar Macrophages. Mol. Biol. Cell
16: 824-834
[Abstract]
[Full Text]
-
Cushion, M. T., Walzer, P. D., Collins, M. S., Rebholz, S., Vanden Eynde, J. J., Mayence, A., Huang, T. L.
(2004). Highly Active Anti-Pneumocystis carinii Compounds in a Library of Novel Piperazine-Linked Bisbenzamidines and Related Compounds. Antimicrob. Agents Chemother.
48: 4209-4216
[Abstract]
[Full Text]
-
Zhang, J., Zhu, J., Imrich, A., Cushion, M., Kinane, T. B., Koziel, H.
(2004). Pneumocystis Activates Human Alveolar Macrophage NF-{kappa}B Signaling through Mannose Receptors. Infect. Immun.
72: 3147-3160
[Abstract]
[Full Text]
-
Walzer, P. D., Ashbaugh, A., Collins, M., Cushion, M. T.
(2001). In Vitro and In Vivo Effects of Quinupristin-Dalfopristin against Pneumocystis carinii. Antimicrob. Agents Chemother.
45: 3234-3237
[Abstract]
[Full Text]
-
Cushion, M. T., Orr, S., Keely, S. P., Stringer, J. R.
(2001). Time between Inoculations and Karyotype Forms of Pneumocystis carinii f. sp. carinii Influence Outcome of Experimental Coinfections in Rats. Infect. Immun.
69: 97-107
[Abstract]
[Full Text]
-
Kaneshiro, E. S., Collins, M. S., Cushion, M. T.
(2000). Inhibitors of Sterol Biosynthesis and Amphotericin B Reduce the Viability of Pneumocystis carinii f. sp. carinii. Antimicrob. Agents Chemother.
44: 1630-1638
[Abstract]
[Full Text]
-
Cushion, M. T., Collins, M., Hazra, B., Kaneshiro, E. S.
(2000). Effects of Atovaquone and Diospyrin-Based Drugs on the Cellular ATP of Pneumocystis carinii f. sp. carinii. Antimicrob. Agents Chemother.
44: 713-719
[Abstract]
[Full Text]
-
Merali, S., Frevert, U., Williams, J. H., Chin, K., Bryan, R., Clarkson, A. B. Jr.
(1999). Continuous axenic cultivation of Pneumocystis carinii. Proc. Natl. Acad. Sci. USA
96: 2402-2407
[Abstract]
[Full Text]
-
Kaneshiro, E. S.
(1998). The Lipids of Pneumocystis carinii. Clin. Microbiol. Rev.
11: 27-41
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.